Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
H. Chen
Observed name:
Haiquan Chen
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center,
Guangdong Provincial People's Hospital,
State Key Laboratory of Genetic Engineering
ORCID:
0000-0003-1689-0549
Observed ORCID:
0000-0003-1689-0549
OpenAlex ID:
A5046459365
OA01.03 Association of Pathologic Regression with EFS in the KEYNOTE-671 Study of Perioperative Pembrolizumab for Early-Stage NSCLC
2024
·
D.R. Jones
, H. Wakelee
, et al.
·
Journal of Thoracic Oncology
·
20
PDF
LBA3 Perioperative pembrolizumab (pembro) plus neoadjuvant chemotherapy (chemo) in early-stage non-small-cell lung cancer (NSCLC): A 4-year update of KEYNOTE-671
2024
·
M. Majem
, M.C. Garassino
, et al.
·
Immuno-Oncology Technology
·
11
PDF
1262P Randomized, open-label phase III study of pembrolizumab (pembro) vs docetaxel (doce) in patients (pts) with previously treated NSCLC with PD-L1 tumour proportion score (TPS) ≥1%: KEYNOTE-033
2020
·
C. Zhou
, J. Feng
, et al.
·
Annals of Oncology
·
6
PDF
Single-cell and spatial transcriptome analyses reveal tumor immunometabolism in lymph node metastasis of lung cancer
2026
·
Yang Zhang
, Wangyang Zhu
, et al.
·
Cancer Biology and Medicine
·
4
PDF
Show more works
View as search
Works count:
4
Citation count:
41
H-index:
4
I10-index:
2
Year
Topic
Type